These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33997885)

  • 1. Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome.
    Vogg N; Kurlbaum M; Deutschbein T; Gräsl B; Fassnacht M; Kroiss M
    Clin Chem; 2021 Jul; 67(7):998-1007. PubMed ID: 33997885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
    Ueland GÅ; Methlie P; Kellmann R; Bjørgaas M; Åsvold BO; Thorstensen K; Kelp O; Thordarson HB; Mellgren G; Løvås K; Husebye ES
    Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
    Ceccato F; Artusi C; Barbot M; Lizzul L; Pinelli S; Costantini G; Niero S; Antonelli G; Plebani M; Scaroni C
    J Endocrinol Invest; 2020 Aug; 43(8):1105-1113. PubMed ID: 32060745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
    J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F; Antonelli G; Frigo AC; Regazzo D; Plebani M; Boscaro M; Scaroni C
    J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.
    Ceccato F; Barbot M; Zilio M; Frigo AC; Albiger N; Camozzi V; Antonelli G; Plebani M; Mantero F; Boscaro M; Scaroni C
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3856-61. PubMed ID: 26274344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
    Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
    Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
    Palmieri S; Morelli V; Polledri E; Fustinoni S; Mercadante R; Olgiati L; Eller Vainicher C; Cairoli E; Zhukouskaya VV; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2013 Mar; 168(3):289-96. PubMed ID: 23211572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited Role of Hair Cortisol and Cortisone Measurement for Detecting Cortisol Autonomy in Patients With Adrenal Incidentalomas.
    Puglisi S; Leporati M; Amante E; Parisi A; Pia AR; Berchialla P; Terzolo M; Vincenti M; Reimondo G
    Front Endocrinol (Lausanne); 2022; 13():833514. PubMed ID: 35222288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism.
    Berndt V; Dahlqvist P; de Verdier J; Ryberg H; Ragnarsson O
    Front Endocrinol (Lausanne); 2022; 13():1028804. PubMed ID: 36506050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overnight 1-mg Dexamethasone Suppression Test for Screening Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS): What Happens when Serum Dexamethasone Is Below Cutoff? How Frequent Is it?
    Farinelli DG; Oliveira KC; Hayashi LF; Kater CE
    Endocr Pract; 2023 Dec; 29(12):986-993. PubMed ID: 37734596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment.
    Genere N; Kaur RJ; Athimulam S; Thomas MA; Nippoldt T; Van Norman M; Singh R; Grebe S; Bancos I
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1221-e1230. PubMed ID: 34648626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
    Khawandanah D; ElAsmar N; Arafah BM
    Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of efficacy between the serum cortisol and 24 hour urine free cortisol in combined dexamethasone suppression test in the diagnosis of Cushing syndrome].
    Lu L; Chen JH; Zhu HJ; Song AL; Li M; Chen S; Pan H; Gong FY; Wang RZ; Xing B; Yao Y; Feng M; Lu ZL
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2150-4. PubMed ID: 27464539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
    Araujo-Castro M; Parra Ramírez P; Martín Rojas-Marcos P; García Centeno R; Gracia Gimeno P; Tomé Fernández-Ladreda M; Sampedro Núñez MA; Higueruela C; Robles Lázaro C
    Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.
    Ceccato F; Barbot M; Albiger N; Antonelli G; Zilio M; Todeschini M; Regazzo D; Plebani M; Lacognata C; Iacobone M; Mantero F; Boscaro M; Scaroni C
    Endocrine; 2018 Mar; 59(3):510-519. PubMed ID: 28956262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.